Current Edition

Argenx

Argenx, already deep into its Vyvgart launch, charts course to become immunology ‘powerhouse’: CEO

Argenx is off to the races with the launch of its new med Vyvgart. With its first FDA-approved drug Vyvgart now rolling out, Argenx is …

Continue Reading →
Bristol Myers Squibb

Bristol Myers Squibb previews new ‘transformation’ corporate brand campaign at annual global patients’ event

Bristol Myers Squibb’s new corporate campaign celebrates transformation—of science, the pharma industry and patients’ lives. It’s the pharma’s first corporate campaign since BMS’ own transformation …

Continue Reading →
clinical

Direct-to-Patient Clinical Trials

Dates: August 09-10, 2018 Location: Philadelphia, PA Positive patient experiences lead to successful clinical trials with high adherence and high participation rates. The pharmaceutical industry’s …

Continue Reading →
MABp1

XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis

First Patient Begins Therapy with MABp1 for Treatment of Atopic Dermatitis XBiotech Inc. (NASDAQ:XBIT) announced today that the first patient has been enrolled in its …

Continue Reading →
bolster

Patient Registries to Bolster Cell- and Gene-Therapy Clinical Trial Data

As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull together …

Continue Reading →
clinical

Somerset Partnership Seeks to Increase Patient Participation in Clinical Trials with TriNetX

Somerset Partnership NHS Foundation Trust, which serves a patient population of 650,000 in the south west region of the U.K., is the first integrated mental …

Continue Reading →
clinical

Polyphor announces enrollment of first patient in Phase III clinical trial for murepavadin – a pathogen-specific antibiotic being developed for the treatment of nosocomial pneumonia

Potentially first new class of antibiotics in Phase III development against Gramnegative pathogens in 50 years Polyphor today announced the enrollment of the first patient …

Continue Reading →
consent

Acea Health announces funding from Catapult Ventures and PUBLIC to launch innovative digital dental and medical consent platform – Flynotes

Acea Health, a digital healthcare company, today announced the completion of a seed funding round to launch Flynotes – its new digital consent platform. The …

Continue Reading →
centricity

Patient Centricity Becomes a Reality with SQN Health

In drug development, patient participation is crucial to the success of clinical trials. The industry recognises the demand for better in-trial patient data and improved …

Continue Reading →
clinical trial

Quanticate launches statistical monitoring services following the ICH GCP E6(R2) addendum

Quanticate, a data-focused clinical research organisation (CRO), has launched its centralised statistical monitoring service (https://www.quanticate.com/centralized-statistical-monitoring) as an extension of its statistical consultancy offering in response …

Continue Reading →